However, activated ICOS+CD38+ cTfh cells dramatically increase in moderate and severe COVID-19 patients compared with mild patients during acute disease, suggesting that activated cTfh cells may reflect recent or ongoing virus encounter and emigration of cTfh cells from the GCs, similar to observations from others48,49. Here, CD38 is linked to COVID-19.